All companies

Ascendis Pharma

Ascendis Pharma is a global biopharmaceutical company headquartered in Denmark, dedicated to improving patients' lives through its innovative TransCon technology platform. The company focuses on developing a pipeline of long-acting prodrug therapies across therapeutic areas such as endocrinology, oncology, and ophthalmology. As a publicly traded entity on NASDAQ, Ascendis operates at a significant scale with a growing international footprint and a robust clinical pipeline. In Spain, Ascendis Pharma maintains a strategic presence in Madrid, supporting its European and international operations. The Spanish office hosts a variety of functions including medical affairs, clinical development, IT, and commercial operations. For international professionals, the company offers a highly collaborative, English-speaking environment and the opportunity to work on cutting-edge biotechnological advancements within a global framework.

Hellerup, Denmark850 employeesFounded 2007Madridascendispharma.com/

Company History

Founded in 2007 in Denmark, Ascendis Pharma was established to apply its proprietary TransCon technology to create better therapeutic outcomes. It went public on the NASDAQ in 2014 and has since expanded its clinical pipeline and global operations across Europe and the United States.

For International Professionals

  • The company uses English as its primary professional language, facilitating integration for international hires.
  • The Madrid office is a key site for global functions, including IT Business Analysis, Clinical Science, and Pharmacovigilance.
  • Ascendis Pharma is a high-growth biotech firm, offering exposure to innovative TransCon technology and global clinical trials.
  • The company maintains a dedicated talent pool for Spain, reflecting a commitment to local and international recruitment in the region.

Open Positions (3)